Long, haven't read it yet, but will.
There's also an article on how some of the new anti-psychotics have some problems. Even the New York Times is weighing in, in an editorial, about the ills of pharmaceutical marketing.
There's also an article on redefining depression as sadness.
Here's an interesting article from newsweek about neuroscience.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment